Elena Bonazzoli

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan D Chow, Tai Michaels, Stefania Bellone, Tobias Mp Hartwich, Elena Bonazzoli, Akiko Iwasak, Eric Song, Alessandro D Santin
Distinct mechanisms of mismatch repair deficiency delineate two modes of response to PD-1 immunotherapy in endometrial carcinoma. Cancer discovery (2022)
Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro, Gary Altwerger, Chanhee Han, Joan Tymon-Rosario, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Peter E Schwartz, Alessandro Santin
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Scientific reports 10 (1) (2020)
Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Gloria S Huang, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E Schwartz, Giovanni Scambia, Alessandro D Santin
Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo. Molecular oncology 14 (3) (2020)

Elena Bonazzoli.css-eqlu8i{font-size:small;padding-left:4px;}